You can buy or sell Walgreens and other stocks, options, ETFs, and crypto commission-free!
Walgreens Boots Alliance, Inc. engages in the provision of drug store services. The company operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. Read More The Retail Pharmacy USA segment engages in pharmacy-led health and beauty retail businesses, which sells its products under brand names Walgreens and Duane Reade. The Retail Pharmacy International segment offers retail stores, which sells products of brands No7, Boots Pharmaceuticals, Botanics, Liz Earle, and Soap & Glory. The Pharmaceutical Wholesale segment supplies medicines, other healthcare products and related services to pharmacies, doctors, health centers, and hospitals. The company was founded in 1901 and is headquartered in Deerfield, IL.
52 Week High
52 Week Low
See what the IHS Markit Score report has to say about Walgreens Boots Alliance Inc.
Walgreens Boots Alliance Inc NASDAQ/NGS:WBA View full report here! Summary ETFs holding this stock are seeing positive inflows Bearish sentiment is low Bearish sentiment Short interest | Positive Short interest is low for WBA with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flow ETF/Index ownership | Positive...
ValoremRx Collaborates with Kroger Specialty Pharmacy to Improve Access and Patient Care
ST. LOUIS, March 19, 2019 /PRNewswire/ -- ValoremRx Specialty Solutions, the group purchasing organization (GPO) formed by a joint venture between Express Scripts and Walgreens, today announced its new collaboration with Kroger Specialty Pharmacy.
Yahoo FinanceMar 15
Why BioScrip Stock Popped and Then Dropped Today
What happened Shares of the home infusion services giant BioScrip (NASDAQ: BIOS) jumped by almost 40% in premarket trading today. Once the market opened, however, the company's stock abruptly reversed course, dropping by more than 30% at its lowest point in early-morning trading. BioScrip's shares have remained under pressure as the day's trading session has unfolded, with its stock falling by 30.3% as of 1:48 p.m. EDT. Scroll to continue with content Ad A green chalkboard chart showing a positive trend...
$1.75 per share
Expected Mar 27, Pre-Market